Dapsone: Indications in Dermatology

Overview / Definition Dapsone, chemically known as diaminodiphenylsulfone, is a sulfone antibiotic that exhibits both antimicrobial and anti-inflammatory properties. Initially developed for the treatment of leprosy, dapsone has found utility in various dermatological conditions, particularly those with an autoimmune or inflammatory component. It is available in oral and topical formulations, with the oral form being more commonly used in dermatology. Epidemiology Dapsone’s use in dermatology spans various populations, particularly in regions endemic to leprosy and conditions like dermatitis herpetiformis. The prevalence of conditions treated with dapsone varies globally: Leprosy: Affects around 200,000 individuals worldwide annually, with higher rates in specific endemic regions. Dermatitis herpetiformis: Estimated prevalence of 1 in 10,000 individuals, often linked with celiac disease. Other conditions: Including bullous pemphigoid and certain granulomatous diseases, though less prevalent. Pathophysiology / Mechanism The exact mechanism by which dapsone exerts its effects is multifactorial: Antimicrobial activity: Dapsone inhibits bacterial dihydropteroate synthase, disrupting folate synthesis, which is critical for bacterial growth. Anti-inflammatory properties: It reduces neutrophil migration and activity, thus lowering inflammation in conditions like dermatitis herpetiformis and bullous pemphigoid. Immune modulation: Dapsone may modulate immune responses, contributing to its efficacy in autoimmune skin disorders. Clinical Presentation Dapsone is indicated for several dermatological conditions, which may present as follows: Dermatitis herpetiformis: Characterized by intensely pruritic vesicular lesions, often on extensor surfaces, associated with gluten sensitivity. Leprosy: Presents with skin lesions, sensory loss, and peripheral neuropathy. Bullous pemphigoid: Clinically presents as tense blisters on erythematous or normal skin, typically in elderly patients. G